Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors

P Jordan1, R Brazåo, M G Boavida

  • 1Laboratório de Oncobiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal.

Oncogene
|December 22, 1999
PubMed

Insights

A novel Rac1b splice variant with a 19-amino acid insertion was identified, predominantly in skin and intestinal tissues. Its elevated expression in colorectal tumors suggests a role in mucosal growth and cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • Rac1, a small GTPase, regulates cell proliferation and signaling pathways.
  • Ras superfamily proteins are crucial in cellular communication.

Purpose of the Study:

  • To identify and characterize novel splice variants of Rac1.
  • To investigate the expression patterns of Rac1 variants in human tissues and colorectal tumors.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) for Rac1 cDNA amplification.
  • Genomic cloning and sequencing to identify novel exons.
  • Quantitative analysis of Rac1 and Rac1b expression in tumor and adjacent tissues.

Main Results:

  • A novel Rac1 splice variant, Rac1b, with a 57-nucleotide insertion (19 amino acids) was discovered.
  • Rac1b is predominantly expressed in skin and intestinal epithelial tissues.
  • Rac1b expression is significantly elevated in colorectal tumors compared to normal adjacent tissues.

Conclusions:

  • The Rac1b variant, featuring an insertion near the switch II region, may alter effector binding and signaling.
  • Rac1b's differential expression suggests its involvement in intestinal mucosa growth and colorectal tumorigenesis.

Related Concept Videos

RACE - Rapid Amplification of cDNA Ends02:35

RACE - Rapid Amplification of cDNA Ends

Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific primer.
Since the...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...